National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 6) (PB 54 of 2014) (Cth)
PB 54 of 2014
National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 6)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 17 July 2014
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
Part 1 Preliminary
Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 6).
(2) This Determination may also be cited as PB 54 of 2014.
Commencement
This Determination commences on 1 August 2014.
Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Acetazolamide
Insert
Aclidinium
[2] Schedule 1, after item dealing with Benzylpenicillin
Insert
Betaine
[3] Schedule 1, after item dealing with Canagliflozin
Omit
Capecitabine
[4] Schedule 1, after item dealing with Methylnaltrexone
Omit
Metoprolol succinate
[5] Schedule 1, after item dealing with Olsalazine
Omit
Omalizumab
[6] Schedule 1, after item dealing with Sevelamer
Omit
Sildenafil
[7] Schedule 1, after item dealing with Tipranavir
Omit
Tirofiban
[8] Schedule 2, after item dealing with Candesartan with Hydrochlorothiazide
Insert
Capecitabine
[9] Schedule 2, after item dealing with Metoprolol
Insert
Metoprolol succinate
[10] Schedule 2, after item dealing with Olmesartan
Insert
Omalizumab
[11] Schedule 2, after item dealing with Sertraline
Insert
Sildenafil
[12] Schedule 2, after item dealing with Tinidazole
Insert
Tirofiban
0
0
0